The NATO Innovation Fund (NIF) has made its first investment in a biotechnology startup. The alliance’s VC arm announced today that it’s co-leading a $35mn Series A round for UK-based Portal Biotech as it seeks to strengthen NATO’s defences against biological warfare. Portal develops portable, AI-powered diagnostic devices capable of detecting pathogens at the single-molecule level. Unlike traditional lab-based systems, its platform is designed for field deployment. It aims to offer rapid, on-site identification of biological threats. Ana Bernardo-Gancedo, senior associate at NATO Innovation Fund, told Reuters that this capability is crucial for defence and security. “We believe it is…This story continues at The Next Web [...]
NATO wants a cloud it can trust under fire. Its technology agency has signed a contract worth about €200 million with Accenture and Italy’s Leonardo to build one. Accenture announced the deal on T [...]
NATO adopts AI platform from Palantir for faster military decision-making, The MSS Nato system aims to automate data analysis that previously required large teams.<br /> The article Project Mave [...]
NATO has signed strategic cybersecurity partnerships with Microsoft, Palo Alto Networks, and ESET, formalising what the alliance describes as non-commercial agreements to strengthen collective resilie [...]
Eight NATO allies have launched an initiative to connect their military satellites into a single networked mega-constellation, marking the Alliance’s most ambitious move yet to treat space as shared [...]
Welsh startup Space Forge has raised $30mn to advance its first commercial in-orbit manufacturing satellite, ForgeStar-2. The NATO Innovation Fund led the funding round, the largest Series A financing [...]
Expeditions, the Warsaw-based venture firm backed by BAE Systems and the NATO Innovation Fund, has closed a €197m ($225m) fund to back the next wave of European defence startups. The raise caps a bo [...]